Riskpilot← Back to searchSign inGet full accessSalfarm Scandinavia AB
ABActiveOrg 5568172943Hyllie Boulevard 34Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20101-4 employees
Revenue 2024
SEK 44,6M
+13% vs 2023
EBITDA margin
27.3%
+24% vs 2023
Equity ratio
45.1%
Financial strength
Net profit 2024
SEK 9,7M
+25% vs 2023
| Revenue | SEK 44,6M | +13% |
| EBITDA | SEK 12,2M | +24% |
| Net profit | SEK 9,7M | +25% |
| Total assets | SEK 23,1M | +6% |
| Equity | SEK 10,4M | +20% |
| Employees | — | — |
Legal name
Salfarm Scandinavia AB
Org number
5568172943
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
31 augusti 2010
Share capital
SEK 50 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas i förening av ledamöterna Firman tecknas i förening av Meldgaard, Danny Sand Olsen, Peter Wendorff Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Aktiebolagets versamhet ska vara att bedriva försäljning av farmaceutiska och kemiska produkter för djur jämte därmed förenlig verksamhet.
Address
Hyllie Boulevard 34
Email
finance@salfram.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 26 893 | 31 606 | 34 125 | 39 401 | 44 640 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 7 033 | 10 022 | 10 822 | 9 811 | 12 166 |
| Depreciation & amort. | −71 | −0 | −0 | −0 | −0 |
| EBIT | 6 962 | 10 022 | 10 822 | 9 811 | 12 166 |
| Net financials | −1 | −12 | −7 | 15 | 113 |
| Profit before tax | 6 961 | 10 010 | 10 815 | 9 826 | 12 278 |
| Tax | −1 502 | −2 068 | −2 244 | −2 079 | −2 563 |
| Net profit | 5 459 | 7 942 | 8 571 | 7 747 | 9 715 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 19 225 | 14 712 | 18 369 | 21 764 | 23 056 |
| Equity | 11 423 | 8 365 | 8 936 | 8 683 | 10 398 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 7 802 | 6 348 | 9 433 | 13 081 | 12 658 |
| Total debt | 7 802 | 6 348 | 9 433 | 13 081 | 12 658 |
EBITDA margin
27.3%
This company
15.8%
Market median
+73% vs market
20202024
Equity ratio
45.1%
This company
38.2%
Market median
+18% vs market
20202024
Return on equity
93.4%
This company
18.4%
Market median
+408% vs market
20202024
Net profit margin
21.8%
This company
8.1%
Market median
+169% vs market
20202024
Asset turnover
1.94×
This company
1.12×
Market median
+73% vs market
20202024
Debt / equity
1.22×
This company
0.62×
Market median
-97% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
HP | Audit | 2020 |
DS Chief Executive Officer | Chief Executive Officer | 2025 |
| Former (2) | ||
MN Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2020 – 2022 |
KH Authorized Recipient of Service | Authorized Recipient of Service | 2020 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2025 | |
| Chairman | 2025 | |
| Board of Directors | 2025 | |
| Former (3) | ||
| Board of Directors | 2020 – 2022 | |
| Board of Directors | 2020 – 2025 | |
| Chairman | 2020 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
SALPHARM HOLDING APS
Salfarm Scandinavia AB (this company)Board members of Salfarm Scandinavia AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hans Peter Wilhelm Otto | Audit | 0 companies |
| Danny Sand Meldgaard | Chief Executive Officer | 0 companies |
| Mette Nørgaard | Deputy Chief Executive Officer | 0 companies |
| Kjell Henrik Adnervik | Authorized Recipient of Service | 0 companies |
| Simon Damkjær Wille | Deputy Board Member | 0 companies |
| Sune Fraes Diernæs | Board of Directors | 0 companies |
| Ronnie Møller-Thorsøe | Board of Directors | 0 companies |
| Peter Wendorff Olsen | Chairman | 0 companies |
| Thomas Bjerregaard Thomsen | Chairman | 0 companies |
| Michael Degn-Mortensen | Board of Directors | 0 companies |